World's Best Scientists 2026 revealed!
Horst Zincke

Horst Zincke

D-Index & Metrics

Medicine

D-Index
120
Citations
46359
World Ranking
3787
National Ranking
2080

Overview

Horst Zincke was affiliated with the Mayo Clinic in the United States during their scientific career. Their research contributions were part of the broader scientific activity at this institution, although specific details about their research topics and publications are not documented here.

No recent papers authored by Horst Zincke are listed, and there are no records of frequent co-authors or common publication venues associated with their work. Similarly, there are no recorded book publications under their name.

The available data does not provide information on main fields of study, subfields, or primary research topics explored by Horst Zincke. Likewise, there are no documented awards or recognitions linked to their career.

Best Publications

  • Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma.

    John C. Cheville;Christine M. Lohse;Horst Zincke;Amy L. Weaver

  • An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score.

    Igor Frank;Michael L. Blute;John C. Cheville;Christine M. Lohse

  • Solid Renal Tumors: An Analysis of Pathological Features Related to Tumor Size

    Igor Frank;Michael L. Blute;John C. Cheville;Christine M. Lohse

  • Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target

    Lieping Chen;Scott E. Strome;Eugene D. Kwon

  • Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

    R. Houston Thompson;Susan M. Kuntz;Bradley C. Leibovich;Haidong Dong

  • Matched comparison of radical nephrectomy vs. nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.

    Wko Lau;ML Blute;AL Weaver;VE Torres

  • Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate Cancer

    Horst Zincke;Joseph E. Oesterling;Michael L. Blute;Erik J. Bergstralh

  • Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.

    Bradley C. Leibovich;Michael L. Blute;John C. Cheville;M B S Christine Lohse

  • Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy

    Bradley C. Leibovich;Michael L. Blute;John C. Cheville;Christine M. Lohse

  • The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus

    Michael L. Blute;Bradley C. Leibovich;Christine M. Lohse;John C. Cheville

  • Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate‐specific antigen testing: 15‐year outcome

    John F. Ward;Jeffrey M. Slezak;Michael L. Blute;Erik J. Bergstralh

  • Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery

    Seth E. Lerner;Craig A. Hawkins;Michael L. Blute;Andreas Grabner

  • Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point?

    Christopher L. Amling;Erik J. Bergstralh;Michael L. Blute;Jeffrey M. Slezak

  • 618: Costimulatory B7-H1 In Renal Cell Carcinoma Patients: Indicator of Tumor Aggressiveness and Potential Therapeutic Target

    R. Houston Thompson;Michael D. Gillett;John C. Cheville;Christine M. Lohse

  • LONG-TERM HAZARD OF PROGRESSION AFTER RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER: CONTINUED RISK OF BIOCHEMICAL FAILURE AFTER 5 YEARS

    Christopher L. Amling;Michael L. Blute;Erik J. Bergstralh;Thomas M. Seay

  • Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome.

    John C Cheville;Christine M Lohse;Horst Zincke;Amy L Weaver

  • Risk of prostate carcinoma death in patients with lymph node metastasis.

    Liang Cheng;Horst Zincke M.D.;Michael L. Blute;Erik J. Bergstralh

  • Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy.

    Michael L. Blute;Erik J. Bergstralh;Angelo Iocca;Beth Scherer

  • Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. Commentary. Authors' reply

    S. E. Lerner;C. A. Hawkins;M. L. Blute;A. Grabner

  • Progression and Survival after Renal-Conserving Surgery for Renal Cell Carcinoma: Experience in 104 Patients and Extended Followup

    William R. Morgan;Horst Zincke

Frequent Co-Authors

Michael L. Blute
Michael L. Blute Harvard University
John C. Cheville
John C. Cheville Mayo Clinic
David G. Bostwick
David G. Bostwick Bostwick Laboratories
Thomas J. Sebo
Thomas J. Sebo Mayo Clinic
Amy L. Weaver
Amy L. Weaver Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in medicine but looking for alternative pathways or flexible learning options, there are several online degrees and careers worth considering. Many students begin with nursing, and there are now online adn programs that offer a practical entry point into the healthcare field while allowing you to study remotely.

For those more interested in the administrative side, best online healthcare administration degree programs can prepare you for leadership roles in hospitals and clinics—often at an accelerated pace.

Not all nursing schools have the same requirements. Some of the do all nursing schools require the teas schools do not require entrance exams like the TEAS or HESI, making that first step in a healthcare career more accessible.

Interested in behind-the-scenes roles? There are also medical billing and coding online schools that accept financial aid, providing vital skills for administrative work in the medical sector.

Best Scientists Citing Horst Zincke